Nipro Pharma Corp.

SEATTLE, June 14, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global prefilled syringes market is estimated to be valued at US$ 6,656.9 million in 2022 and is expected to exhibit a CAGR of 10.6% during the forecast period (2022-2030). Key Trends and Analysis of the Global Prefilled Syringes Market: Major players operating in the market are focusing on adopting strategies such as product launch, which is expected to drive the market growth over the forecast period. For instance, in January 2022, Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, launched Diazepam injection, indicated for the management of anxiety, convulsive seizures, and alcohol withdrawals, in prefilled syringe form. Key Market Takeaways: The global prefilled syringes market is expected to exhibit a CAGR of 10.6% during the forecast period due to the increasing adoption of strategies such as public-private partnerships to increase the capacity of manufacturing prefilled syringes. For instance, in March 2020, ApiJect Systems America, a public benefit corporation, joined with the U. S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response, which leads the nation's medical and public health preparedness for response to, and recovery from disasters and public health emergencies, in announcing the launch of a public-private partnership dedicated to creating a U.S.-based high-volume, high-speed, emergency drug packaging solution, establishing surge capacity for mass-manufacturable prefilled syringes. Among types, the safety prefilled syringes segment is expected to dominate the segment growth over the forecast period, owing to product launches by the key players operating in the market. For instance, in October 2021, West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drugs and healthcare products, announced its latest offering for the Indian domestic market with the launch of the NovaGuard SA Pro Safety System, a single-use accessory for prefilled ISO standard 0.5mL staked needle syringes. Request Sample Copy of this Report at On the basis of material types, the glass segment is expected to dominate the segment growth over the forecast period, owing to the increasing adoption of inorganic strategies such as collaborations and agreements by the key players in the market. For instance, on May 4th 2022, Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, signed an agreement with Owen Mumford Ltd, a leading medical device developer for its Aidaptus auto-injector. Aidaptus is a 2-step, single use auto-injector with a versatile design that accommodates both 1mL and 2.25 mL prefilled glass syringes in the same base device. Key players operating in the global prefilled syringes market include BD, Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Inc., Vetter Pharma International, Stevanato Group, Terumo Corporation, Catalent, Inc., Weigao group, NIPRO PHARMA CORPORATION, Oval Medical Technologies Ltd., and SHL Medical AG. Request for Customization at Detailed Segmentation: Global Prefilled Syringes Market, By Type: Conventional Prefilled Syringes Safety Prefilled Syringes Global Prefilled Syringes Market, By Material Type: Glass Plastic Global Prefilled Syringes Market, By Design: Single-chamber Dual-chamber Customized Global Prefilled Syringes Market, By End User: Hospitals Clinics Others Global Prefilled Syringes Market, By Region: North America By Country: U.S. Canada Europe By Country: U.K. Germany Italy France Spain Russia Rest of Europe Asia Pacific By Country: China India Japan ASEAN Australia South Korea Rest of Asia Pacific Latin America By Country: Brazil Mexico Argentina Rest of Latin America Middle East & Africa By Country: GCC Countries Israel South Africa Rest of Middle East & Africa Buy this Complete Report Now at Find related trending report below: Small Molecule Prefilled Syringes Market, by Drug Class (Cardiovascular Drugs, Neurology Drugs, Analgesics, Adjuvants, and Others), by Material Type (Glass, and Plastic & Polymer), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients. Contact Us: Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: [email protected] Website: Follow Us: LinkedIn | Twitter Logo: SOURCE Coherent Market Insights